$GALT Up 28%! 🚀 🔹 Galectin Therapeutics catching momentum as biotech traders focus on its belapectin MASH cirrhosis program 📈 🔹 Recent EASL 2026 data highli

Breakout Stocks • 2026-06-23 16:44 UTC • By Billy Odell Tucker-Robinson

$GALT Up 28%! 🚀 🔹 Galectin Therapeutics catching momentum as biotech traders focus on its belapectin MASH cirrhosis program 📈 🔹 Recent EASL 2026 data highlighted belapectin’s potential to modify disease progression in advanced MASH cirrhosis 🔥 🔹 NAVIGATE trial analyses showed risk reduction si…

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly